Neoadjuvant Chemotherapy Therapy Blogs This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

An Interview with Orthopaedic Oncologist Dr. Vincent Ng
Dr. Vincent Ng is an orthopaedic oncologist with the University of Maryland Greenebaum Comprehensive Cancer Center and an Assistant Professor or Orthopaedics with the University of Maryland School of Medicine. Dr. Ng specializes in treating bone cancer and soft tissue sarcoma. Below he answers common questions about orthopaedic oncology. What is an orthopaedic oncologist? How do they differ from surgical oncologists? “An orthopaedic oncologist specializes in bone and soft tissue tumors. I treat any adult or pediatric patient with any bone or soft tissue tumor/lesion/mass, whether benign or malignant, whether it is...
Source: Life in a Medical Center - June 2, 2017 Category: Universities & Medical Training Authors: UMMC Tags: Cancer Doctors bone cancer oncology orthopedics Source Type: blogs

Carcinoma Rectum :MRI
Discussion by Dr MGK Murthy, Dr GA PrasadMR- useful to assist staging & identify patients who may benefit from preoperative chemotherapy–radiation therapy, and in surgical planning.Currently, surgical resection with stage-appropriate neoadjuvant combined-modality therapy is the mainstay in the treatment of rectal cancer.Total mesorectal excision (TME) has reduced the prevalence of local recurrence from 38% to less than 10%. TME is surgical en bloc resection of the primary tumor and the mesorec tum by means of dissection along the mesorectal fascial plane or the circumferential resection margi...
Source: Sumer's Radiology Site - April 28, 2017 Category: Radiology Authors: Sumer Sethi Source Type: blogs

In An Era Of Bold New Cancer Treatments An Older Drug Shows Real Promise For Advanced Prostate Cancer
The annual meeting of the American Society of Clinical Oncology here in Chicago is a place where many commercial interests jostle for attention to make their latest promising therapy the star of the show. But this weekend, a standard widely available generic drug stole the show by producing incredible results in improving survival for men with advanced prostate cancer. And that has some of us asking, "Why did it take so long to find out? The drug is docetaxel, which for decades has been used to treat a number of cancers, including prostate cancers. We have known for some time that it is helpful in the treatment of men who...
Source: Dr. Len's Cancer Blog - June 2, 2014 Category: Cancer Authors: Dr. Len Tags: Cancer Care Medications Prostate Cancer Treatment Source Type: blogs

New nanopharmaceutical may help overcome resistance to specific anticancer drugs
Conclusions: Results generated through this translational research plan suggest that CRLX101 can overcome HIF-1α-mediated acquired resistance to antiangiogenic drugs, assisting the use of CRLX101 in combination with antiangiogenic medicines as an exciting new paradigm for the treatment of cancer. Related Posts:Cleveland Clinic’s preventive breast cancer vaccine…Harvard Stem Cell Institute publishes initial clinical trialImportant advance in the fight against skin cancerNew IBS treatment shows possible in Phase 2 researchNew blood test could help millions of patients with&hellip...
Source: My Irritable Bowel Syndrome Story - October 21, 2013 Category: Other Conditions Authors: Ken Tags: IBS News Source Type: blogs

World Class
This is what can happen when a private practice surgeon refers a complicated colon cancer patient to a medical oncologist affiliated with a certain multinational, gigantic world-famous non-profit health care system. Let's say the surgeon is asked to see a patient with a large bowel obstruction. Perhaps the colonoscopy demonstrated a high grade constricting lesion in the distal sigmoid/upper rectum and the CT scan revealed a massive, locally infiltrating mass invading into the bladder and a possible liver lesion. Perhaps the patient has lost 30 lbs recently and has noted foul smelling material in her urine. &nb...
Source: Buckeye Surgeon - May 3, 2013 Category: Surgeons Authors: Jeffrey Parks MD Source Type: blogs

World Class
This is what can happen when a private practice surgeon refers a complicated colon cancer patient to a medical oncologist affiliated with a certain multinational, gigantic world-famous non-profit health care system.Let's say the surgeon is asked to see a patient with a large bowel obstruction. Perhaps the colonoscopy demonstrated a high grade constricting lesion in the distal sigmoid/upper rectum and the CT scan revealed a massive, locally infiltrating mass invading into the bladder and a possible liver lesion. Perhaps the patient has lost 30 lbs recently and has noted foul smelling material in her urine. Th...
Source: Buckeye Surgeon - May 2, 2013 Category: Surgery Authors: Jeffrey Parks MD FACS Source Type: blogs

FDA Center for Drug and Evaluation Research Exclusivity Board, Data Partnership and Neoadjuvant Therapies
According to a recent post from the FDA Law Blog, the Food and Drug Administration (FDA) recently announced that the Agency has established within the Center for Drug Evaluation and Research (“CDER”) an Exclusivity Board “to provide oversight and recommendations regarding exclusivity determinations made by the Center, with a primary focus on clarity and consistency of decisions.” “The CDER Exclusivity Board will oversee certain exclusivity determinations, including whether and what type of exclusivity should be granted and the appropriate scope of exclusivity grants,” according to the announcement. The...
Source: Policy and Medicine - January 3, 2013 Category: Health Medicine and Bioethics Commentators Authors: Thomas Sullivan Source Type: blogs